![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.globenewswire.com/news-release/2024/08/02/2923541/0/en/Arch-Biopartners-Cilastatin-Drug-Candidate-to-Participate-in-the-PONTIAC-Phase-II-Trial-Targeting-Acute-Kidney-Injury-Caused-by-Drug-Toxins.html
https://www.globenewswire.com//news-release/2024/02/27/2835883/0/en/Arch-Biopartners-Has-Pre-IND-Meeting-With-FDA-to-Discuss-Repurposing-Cilastatin-as-a-New-Treatment-to-Prevent-Acute-Kidney-Injury.html
https://endpts.com/merck-defends-antibiotics-approval-from-2019-as-bmj-investigation-points-to-decline-in-fda-standards/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-22-2023-51785.pdf
https://www.fiercepharma.com/pharma/merck-telegraphs-closure-pa-antibiotics-plant-employs-300
https://investors.merck.com/news/press-release-details/2020/FDA-Approves-Mercks-RECARBRIO-imipenem-cilastatin-and-relebactam-for-the-Treatment-of-Adults-with-Hospital-Acquired-and-Ventilator-Associated-Bacterial-Pneumonia-HABPVABP/default.aspx
https://www.businesswire.com/news/home/20200506005158/en/Results-Phase-3-Trial-Evaluating-Efficacy-Safety
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-9-12-december-2019
https://endpts.com/merck-touts-phase-iii-data-for-antibacterial-recarbrio-sanofi-to-ax-200-jobs-in-japan-report/
https://www.fiercepharma.com/pharma/as-officials-grapple-antimicrobial-resistance-merck-scores-fda-approval-for-new
https://in.reuters.com/article/us-merck-co-fda/mercks-treatment-for-urinary-abdominal-infections-gets-fda-approval-idINKCN1UC19W
https://www.biospace.com/article/fda-action-alert-karyopharm-merck-and-celgene/
https://www.fiercepharma.com/pharma/merck-scores-zerbaxa-label-expansion-years-after-cubist-buyout
http://www.pharmatimes.com/news/fda_accepts_two_of_msds_new_drug_applications_1277462
https://www.pharmacompass.com/pdf/news/hospira-healthcare-india-pvt-ltd-on-fda-import-alert-list-1549480434.pdf
http://www.prnewswire.com/news-releases/shionogi-announces-positive-top-line-results-for-cefiderocol-pivotal-cuti-clinical-trial-300389912.html
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0346-2015&w=01282015&lang=eng